Dario   investors - sep 26
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
851
On Slideshare
851
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
21
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. LabStyle Innovations Corp. (DRIO: OTCBB) End to End Smart Solutions for Diabetics in a Mobile Age Corporate Presentation - September 27, 2013 Aegis Healthcare Conference LasVegas Dr. Oren Fuerst, Executive Chairman & Erez Raphael, President/CEO Dario Saturday, September 28, 13
  • 2. Disclaimer Regarding Forward-Looking Statements   This presentation of LabStyle Innovations Corp. (the “Company”) and statements of the Company’s management or agents related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act").  Words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions all denote forward-looking statements within the meaning of the Act.  Factors that could cause or contribute to such differences include the Company’s compliance with regulatory requirements, the Company’s status as a new public company, the impact of current and any future competition, as well as other factors and risks discussed in the Company's filings with the U.S. Securities and Exchange Commission.   Readers are cautioned that actual results may differ significantly from those set forth in the forward-looking statements.The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.   In addition, readers are cautioned that any estimates, forecasts or projections contained in this presentation or as may be discussed by Company management or its agents have been prepared by Company management in good faith on a basis believed to be reasonable. However, such estimates, forecasts and projections involve significant elements of subjective judgment and analysis and no representation can be made as to their attainability. No representation or warranty (express or implied) is made or is to be relied upon as a promise or representation as to the future performance of the Company. Readers are cautioned that such estimates, forecasts or projections have not been audited and have not been prepared in conformance with generally accepted accounting principles. Saturday, September 28, 13
  • 3. Delaware Company Founded 2011, based on IP from 2010 Share Price $2.79. Market Cap $55M Shares Outstanding 19.284M (Float ~ 11.5M shares) Public Since March 2013 (Through S1) Raised $16M, including $10M in May 2013 Developer of Dario, an all-in-one mobile and cloud based diabetes management system with glucose measurement device, data capture and analytics, sharing and social features enabling proactive care ‫


  • 4. נגטיב‬‫ו‬‫לוג‬ ‫


  • 5. נגטיב‬‫ו‬‫לוג‬ ‫


  • 6. נגטיב‬‫ו‬‫לוג‬ LabStyle Innovations (DRIO:OTCBB) Corporate Snapshot Saturday, September 28, 13
  • 7. Saturday, September 28, 13
  • 8. 2013 2022 $12b $27b (Up 170%) 400mdiabetics 20-30%insulin dependent 80-120mPrimary initial target users Global glucose self-monitoring market (primarily test strips) Large and Growing Global Market Saturday, September 28, 13
  • 9. 2011 2018 $37b $72b 2011 2030 10% CAGR 370m 550m Source:Transparency Market Research, "Global Diabetes Devices Market and Diabetes Drugs Market - Industry Scenario,Trends,Analysis, Size, Share and Forecast, 2011 - 2018," Global Diabetes (therapeutics devices and drugs) market Number of Diabetics Worldwide Diabetes:A Large and Growing Market Saturday, September 28, 13
  • 10. Creating the ‘Artificial Diabetes Brain’, as a springboard of services and products leading to healthier and better life of diabetics worldwide. Dario Value Proposition Saturday, September 28, 13
  • 11. Creating the ‘Artificial Diabetes Brain’, as a springboard of services and products leading to healthier and better life of diabetics worldwide. Dario Value Proposition Strips Saturday, September 28, 13
  • 12. Insulin Creating the ‘Artificial Diabetes Brain’, as a springboard of services and products leading to healthier and better life of diabetics worldwide. Dario Value Proposition Strips Saturday, September 28, 13
  • 13. Diabetes Complications Insulin Creating the ‘Artificial Diabetes Brain’, as a springboard of services and products leading to healthier and better life of diabetics worldwide. Dario Value Proposition Strips Saturday, September 28, 13
  • 14. Diabetes Complications Insulin Creating the ‘Artificial Diabetes Brain’, as a springboard of services and products leading to healthier and better life of diabetics worldwide. Dario Value Proposition Strips Saturday, September 28, 13
  • 15. Dario:“Artificial Diabetes Brain”, All-in-one mobile and cloud based diabetes management system with glucose measurement device, data capture and analytics, sharing and social features -Concluded usability and accuracy studies -Obtained CE Mark for Europe. UK, Belgium, Italy distribution agreements - Software launch on European Appstore Q4 - 510(k) path for the USA -Reimbursable, recurring, test strips revenue based model -Expanding into a hub of solutions for Diabetics (e.g. revenue from integration with smart insulin pens; clinical studies; product market testing) -More than 400M diabetics worldwide (close to 100M are insulin dependent). -$12bn test strips market and growing ($37bn overall diabetes market) -Very little real innovation ‫


  • 16. נגטיב‬‫ו‬‫לוג‬ ‫


  • 17. נגטיב‬‫ו‬‫לוג‬ ‫


  • 18. נגטיב‬‫ו‬‫לוג‬ ‫


  • 19. נגטיב‬‫ו‬‫לוג‬ LabStyle Innovations InvestmentTheme Saturday, September 28, 13
  • 20. Enter Dario www.mydario.com Saturday, September 28, 13
  • 21. Enter Dario www.mydario.com Saturday, September 28, 13
  • 22. Saturday, September 28, 13
  • 23. Social Network - Crowd Source Multi Mobile Platform - Cloud Service Monitoring Dario Software Easy to use, Stylish,All in One Monitoring Device Actionable Personalized Insights Improve Diabetic Health - Monitoring toTherapy Dario End to End Lifecycle Therapy Insulin (Pens; pumps), Diabetic Food, Exercise, Behavior Saturday, September 28, 13
  • 24. 1990s 2000s Glucose Self-Monitoring Devices Have changed much over the past years Saturday, September 28, 13
  • 25. http://chocolateonmycranium.blogspot.com/2011/05/changes.html#.T8Yc05kthbo Device Lancer Strips A bulky Kit Cumbersome to Carry Saturday, September 28, 13
  • 26. Data is Lost Saturday, September 28, 13
  • 27. Smartphone-driven Glucose Meter Lancing device and strip container Patent-pending technology Dario The Device Pocket Size Glucose Meter Stylish and easy to use Saturday, September 28, 13
  • 28. Community Based - Learn and Share Data Analysis and Insights Proactive Recommendation Based on Pattern Recognition EndTo End Diabetes Lifestyle Management (Food, Exercise, Insulin Intake) ‫


  • 29. נגטיב‬‫ו‬‫לוג‬ ‫


  • 30. נגטיב‬‫ו‬‫לוג‬ ‫


  • 31. נגטיב‬‫ו‬‫לוג‬ ‫


  • 32. נגטיב‬‫ו‬‫לוג‬ Comprehensive Platform - Patient, Care Giver, Professional Healthcare ‫


  • 33. נגטיב‬‫ו‬‫לוג‬ Dario The Software Goals and Objectives via Gamification ‫


  • 34. נגטיב‬‫ו‬‫לוג‬ Saturday, September 28, 13
  • 35. Dario The App Saturday, September 28, 13
  • 36. Physician Dietitian Nurse Other care givers Patient REAL-TIME DATA HISTORICAL DATA TAILOR-MADE DATA ANALYZED DATA Dramatically improving information flow among patients and care givers Saturday, September 28, 13
  • 37. Phone + meter Meter + lancer Current Attempts Combine Hardware - Rather than providing an E2E Customer Experience Saturday, September 28, 13
  • 38. Combining direct to consumers and distributors model Test strips are typically fully reimbursed;Alignment with HC Insurance Agenda Data enables a natural expansion into insulin delivery (e.g. smart insulin pen) Initially: Recurring, high margin revenue from sales of strips ‫


  • 39. נגטיב‬‫ו‬‫לוג‬ ‫


  • 40. נגטיב‬‫ו‬‫לוג‬ ‫


  • 41. נגטיב‬‫ו‬‫לוג‬ ‫


  • 42. נגטיב‬‫ו‬‫לוג‬ Platform enables revenue from clinical studies and data (e.g. pharma; food) User base enables product partnerships (e.g. pharma; food) ‫


  • 43. נגטיב‬‫ו‬‫לוג‬ ‫


  • 44. נגטיב‬‫ו‬‫לוג‬ Revenue Model Highlights ‫


  • 45. נגטיב‬‫ו‬‫לוג‬ Illustration: 5 Strips/day*$0.5/Strip*365days/year*100,000 clients>$90M/year Saturday, September 28, 13
  • 46. Saturday, September 28, 13
  • 47. Saturday, September 28, 13
  • 48. Saturday, September 28, 13
  • 49. Oren Fuerst, PhD Executive Chairman Erez Raphael CEO & President Tal Givoly CTO Seasoned medtech entrepreneur and investor Former facultyYale and Columbia Business School Extensive experience in medical devices and data mgt Former Chief Scientist of Amdocs (NYSE:DOX) More than 25 years in software development Software inventor with more 25+ granted patents Prof. Itamar Raz MD Head of SAB Head of Diabetes Unit and Research Center, Hadassah Medical Center; Israel National Council of Diabetes of the Israel Ministry of Health; President, Israel Diabetes Research Group. 20 years of experience in product design, development and commercialization. Formerly with Amdocs (NYSE: DOX) and Nokia-Siemens Shosh Friedman VP Clinical and Regulatory Affairs Former SVP Clinical and Regulatory Affairs at Given Imaging (NASDAQ:GIVN). More than 20 years in clinical, regulatory affairs and QA systems. Experienced ManagementTeam Saturday, September 28, 13
  • 50. Oren Fuerst, PhD Co-Founder Malcolm Hoenlein Prof. Nahum Melumad PhD Adam Stern Seasoned entrepreneur and investor Founder ofTevel Global & Strategic Models Former faculty Columbia Business School. Extensive experience in medical devices and data management CEO, ExecutiveVice-Chairman, Conference of Major American Jewish Organizations Director, Council of Foreign Relations Professor of Accounting and Business Law, Columbia Business School Consultant to J&J, Bristol-Myers, GE Head of Private Equity Banking at Aegis Capital and CEO of SternAegisVentures Director inVivo, Organovo, Prolor 20+ years of investment experience David Weintraub MD Co-Founder Co-founder, Medical Director Ramat-Aviv MC Serial entrepreneur and inventor Founder ofVersamed (acquired by GE) Itamar Raz MD Head of Diabetes Unit, Hadassah Medical Center Head, Israel National Council of Diabetes President, Israel Diabetes Research Group Board of directors Saturday, September 28, 13
  • 51. Dario:“Artificial Diabetes Brain”,All-in-one mobile and cloud based diabetes management system with glucose measurement device, data capture and analytics, sharing and social features -Concluded usability and accuracy studies -Obtained CE Mark for Europe. UK, Belgium, Italy distribution agreements - Software launch on European Appstore Q4 - 510(k) path for the USA -Reimbursable, recurring, test strips revenue based model -Expanding into a hub of solutions for Diabetics (e.g. revenue from integration with smart insulin pens; clinical studies; product market testing) -More than 400M diabetics worldwide (close to 100M are insulin dependent). -$12bn test strips market and growing ($37bn overall diabetes market) -Very little real innovation ‫


  • 52. נגטיב‬‫ו‬‫לוג‬ ‫


  • 53. נגטיב‬‫ו‬‫לוג‬ ‫


  • 54. נגטיב‬‫ו‬‫לוג‬ ‫


  • 55. נגטיב‬‫ו‬‫לוג‬ LabStyle Innovations InvestmentTheme Saturday, September 28, 13
  • 56. Dario ThankYou! Saturday, September 28, 13
  • 57. Saturday, September 28, 13
  • 58. Physician Dietitian Nurse Other care givers Patient Big Data and Proactive Care at its best REAL-TIME DATA HISTORICAL DATA TAILOR-MADE DATA ANALYZED DATA •Pattern Recognition to yield personalization of Insulin Regimen •New regimen tested in real time •Real-Time clinical and marketing studies potential (Recruitment; Data capture;Analysis) •Prediction of Diabetes complications and the need for immediate actions Saturday, September 28, 13